These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A role for histone deacetylases in the cellular and behavioral mechanisms underlying learning and memory. Mahgoub M; Monteggia LM Learn Mem; 2014 Oct; 21(10):564-8. PubMed ID: 25227251 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders. Konsoula Z; Barile FA J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase-3: Friend and foe of the brain. D'Mello SR Exp Biol Med (Maywood); 2020 Jul; 245(13):1130-1141. PubMed ID: 32486848 [TBL] [Abstract][Full Text] [Related]
6. Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases. Sharma S; Sarathlal KC; Taliyan R CNS Neurol Disord Drug Targets; 2019; 18(1):11-18. PubMed ID: 30289079 [TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase Inhibitors as Cognitive Enhancers and Modifiers of Mood and Behavior. Pal D; Sahu P; Mishra AK; Hagelgans A; Sukocheva O Curr Drug Targets; 2023; 24(9):728-750. PubMed ID: 36475351 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders. Gupta R; Ambasta RK; Kumar P Life Sci; 2020 Feb; 243():117278. PubMed ID: 31926248 [TBL] [Abstract][Full Text] [Related]
9. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis. Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408 [TBL] [Abstract][Full Text] [Related]
10. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders. Ganai SA; Banday S; Farooq Z; Altaf M Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674 [TBL] [Abstract][Full Text] [Related]
12. Cognitive function in health and disease: the role of epigenetic mechanisms. Mungenast AE; Tsai LH Neurodegener Dis; 2012; 10(1-4):191-4. PubMed ID: 22301371 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Central Nervous System Development by Class I Histone Deacetylases. D'Mello SR Dev Neurosci; 2019; 41(3-4):149-165. PubMed ID: 31982872 [TBL] [Abstract][Full Text] [Related]
14. Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond. Konstantinopoulos PA; Karamouzis MV; Papavassiliou AG Expert Opin Investig Drugs; 2007 May; 16(5):569-71. PubMed ID: 17461732 [TBL] [Abstract][Full Text] [Related]
15. The epigenetic bottleneck of neurodegenerative and psychiatric diseases. Sananbenesi F; Fischer A Biol Chem; 2009 Nov; 390(11):1145-53. PubMed ID: 19747081 [TBL] [Abstract][Full Text] [Related]
16. The potential of HDAC inhibitors as cognitive enhancers. Gräff J; Tsai LH Annu Rev Pharmacol Toxicol; 2013; 53():311-30. PubMed ID: 23294310 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of airway inflammation. Adcock IM; Tsaprouni L; Bhavsar P; Ito K Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468 [TBL] [Abstract][Full Text] [Related]
18. Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration. Ganai SA; Ramadoss M; Mahadevan V Curr Neuropharmacol; 2016; 14(1):55-71. PubMed ID: 26487502 [TBL] [Abstract][Full Text] [Related]
19. Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities. Pirooznia SK; Elefant F Front Cell Neurosci; 2013; 7():30. PubMed ID: 23543406 [TBL] [Abstract][Full Text] [Related]